JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.92B |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.54B |
| 3 |
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
|
+$1.2B |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 5 |
iShares MBS ETF
MBB
|
+$780M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.34B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.3B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.6B |
| 4 |
Texas Instruments
TXN
|
+$1.53B |
| 5 |
Tesla
TSLA
|
+$1.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.53% |
| 2 | Financials | 10.45% |
| 3 | Consumer Discretionary | 10.06% |
| 4 | Healthcare | 9.81% |
| 5 | Industrials | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
1351
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $27.8M | ﹤0.01% |
1,782,635
+802,865
| +82% | +$9.41M |
|
1352
Bausch Health
BHC
$2.37B
| $27.8M | ﹤0.01% |
1,336,488
+67,094
| +5% | +$1.25M |
|
1353
Teva Pharmaceuticals
TEVA
$42.6B
| $27.8M | ﹤0.01% |
2,875,887
-1,409,275
| -33% | -$13.5M |
|
1354
Denali Therapeutics
DNLI
$3.97B
| $27.7M | ﹤0.01% |
331,093
+22,239
| +7% | +$1.34M |
|
1355
Jabil
JBL
$38.8B
| $27.7M | ﹤0.01% |
650,855
-53,805
| -8% | -$2.04M |
|
1356
Lear
LEA
$8.16B
| $27.7M | ﹤0.01% |
174,024
-29,944
| -15% | -$4.21M |
|
|
BLUE
1357
DELISTED
bluebird bio
BLUE
| $27.6M | ﹤0.01% |
49,199
+33,049
| +205% | +$20.9M |
|
1358
Hain Celestial
HAIN
$53.9M
| $27.6M | ﹤0.01% |
686,559
-1,178,507
| -63% | -$42.9M |
|
1359
SITE Centers
SITC
$158M
| $27.6M | ﹤0.01% |
3,491,073
-91,805
| -3% | -$641K |
|
|
PRSP
1360
DELISTED
Perspecta Inc. Common Stock
PRSP
| $27.5M | ﹤0.01% |
1,141,307
-58,438
| -5% | -$1.25M |
|
1361
Scansource
SCSC
$1.06B
| $27.4M | ﹤0.01% |
1,040,562
+3,017
| +0.3% | +$72.4K |
|
1362
PUT
AbbVie
ABBV
$443B
| $27.4M | ﹤0.01% |
255,800
+40,500
| +19% | +$3.89M |
|
1363
Williams-Sonoma
WSM
$28.5B
| $27.3M | ﹤0.01% |
535,454
-75,398
| -12% | -$3.86M |
|
1364
Coca-Cola Europacific Partners
CCEP
$47.5B
| $27.1M | ﹤0.01% |
652,182
+15,305
| +2% | +$647K |
|
1365
iShares MSCI Singapore ETF
EWS
$1.16B
| $27.1M | ﹤0.01% |
1,262,049
+245,775
| +24% | +$5M |
|
|
FISV
1366
CALL
Fiserv Inc
FISV
$29.5B
| $26.9M | ﹤0.01% |
236,600
+225,900
| +2,111% | +$24.3M |
|
1367
RPM International
RPM
$14.5B
| $26.9M | ﹤0.01% |
296,496
-11,237
| -4% | -$991K |
|
|
NUVA
1368
DELISTED
NuVasive, Inc.
NUVA
| $26.9M | ﹤0.01% |
477,394
-69,059
| -13% | -$3.4M |
|
1369
Brinker International
EAT
$10.2B
| $26.9M | ﹤0.01% |
474,964
-65,887
| -12% | -$3.25M |
|
1370
CALL
Bristol-Myers Squibb
BMY
$132B
| $26.8M | ﹤0.01% |
432,000
+300,000
| +227% | +$18.4M |
|
1371
Ingredion
INGR
$6.63B
| $26.8M | ﹤0.01% |
340,429
+129,768
| +62% | +$10M |
|
1372
Domino's
DPZ
$11.6B
| $26.8M | ﹤0.01% |
69,777
-82,338
| -54% | -$32.4M |
|
1373
AdaptHealth
AHCO
$760M
| $26.7M | ﹤0.01% |
712,005
+696,679
| +4,546% | +$21.6M |
|
|
ALE
1374
DELISTED
Allete
ALE
| $26.7M | ﹤0.01% |
431,600
+172,739
| +67% | +$9.79M |
|
1375
Bunge Global
BG
$21.7B
| $26.7M | ﹤0.01% |
407,425
+124,538
| +44% | +$7.27M |
|
Similar funds
JP Morgan Chase's Q4 2020 Portfolio in Review
As of Q4 2020, JP Morgan Chase held 6,220 positions worth $681B, up 14% from $595B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2020 filing shows 531 new, 2,858 increased, 1,755 reduced and 504 closed positions. Its largest new stake was Apartment Income REIT Corp.: 5,811,161 shares worth $223M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2020 buy was Apartment Income REIT Corp.: 5,811,161 shares worth $223M.
- JP Morgan Chase added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $3.92B increase.
- JP Morgan Chase's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.34B.
- JP Morgan Chase fully exited Bank of America Series L in Q4 2020, selling an estimated $117M.
- JP Morgan Chase's ten largest holdings make up 16% of its $681B portfolio in Q4 2020.
- JP Morgan Chase opened 531 new positions and closed 504 in Q4 2020.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $681B.
Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.